BVS (Bioventus Inc. Class A Common Stock)

Insider Trading Activity

Every open-market purchase and sale reported by BVS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
9
code S
Reporting Insiders
21
current holders
BVS — Recent Form 4 Transactions (latest 2026-06-04)
FiledInsiderRole TypeSharesValue
2026-06-04 WILLIAM A HAWKINS Director M
2026-06-04 SUSAN M STALNECKER Director M
2026-06-04 Philip G. Cowdy Director M
2026-06-04 GUY P NOHRA Director M
2026-06-04 Michelle McMurry-Heath Director M
2026-06-04 Pat Beyer Director M
2026-06-04 GUIDO J NEELS Director M
2026-06-04 John A. Bartholdson Director M
2026-06-04 Mary Kay Ladone Director M
2026-06-04 MARTIN P SUTTER Director M
2026-04-14 Philip G. Cowdy Director A
2026-04-14 Philip G. Cowdy Director A
2026-04-14 Anthony D'Adamio SVP & General Counsel MIXED
2026-04-14 KATRINA J CHURCH SVP & Chief Compliance Officer MIXED
2026-04-14 Mark Leonard Singleton SVP & CFO MIXED
2026-03-24 Mark Leonard Singleton SVP & CFO MIXED
2026-03-17 Mark Leonard Singleton SVP & CFO MIXED
2026-03-17 Anthony D'Adamio SVP & General Counsel MIXED
2026-03-17 KATRINA J CHURCH SVP & Chief Compliance Officer MIXED
2026-03-17 Robert E Claypoole President and CEO MIXED
2026-03-13 Michelle McMurry-Heath Director Sell
2026-02-18 Mark Leonard Singleton SVP & CFO MIXED
2026-02-18 Anthony D'Adamio SVP & General Counsel MIXED
2026-02-18 KATRINA J CHURCH SVP & Chief Compliance Officer MIXED
2026-01-13 Robert E Claypoole President and CEO MIXED
2025-12-08 GUY P NOHRA Director Sell
2025-11-10 Michelle McMurry-Heath Director Sell
2025-06-10 John A. Bartholdson Director M
2025-06-05 John A. Bartholdson Director M
2025-06-04 GUIDO J NEELS Director M
2025-06-04 Philip G. Cowdy Director A
2025-06-04 WILLIAM A HAWKINS Director M
2025-06-04 SUSAN M STALNECKER Director M
2025-06-04 MARTIN P SUTTER Director M
2025-06-04 Mary Kay Ladone Director M
2025-06-04 Pat Beyer Director M
2025-06-04 Michelle McMurry-Heath Director M
2025-06-04 GUY P NOHRA Director M
2025-04-15 KATRINA J CHURCH SVP & Chief Compliance Officer Sell
2025-04-15 Anthony D'Adamio SVP & General Counsel Sell
2025-04-15 Mark Leonard Singleton SVP & CFO Sell
2025-04-11 Mark Leonard Singleton SVP & CFO M
2025-04-11 KATRINA J CHURCH SVP & Chief Compliance Officer M
2025-04-11 Anthony D'Adamio SVP & General Counsel M
2025-03-25 Mark Leonard Singleton SVP & CFO Sell
2025-03-21 Mark Leonard Singleton SVP & CFO M
2025-03-18 Anthony D'Adamio SVP & General Counsel Sell
2025-03-18 KATRINA J CHURCH SVP & Chief Compliance Officer Sell
2025-03-14 Anthony D'Adamio SVP & General Counsel M
2025-03-14 KATRINA J CHURCH SVP & Chief Compliance Officer M
BVS — Current Insider Holders
InsiderRole Shares HeldValue
Director 13,138,847
Director 7,051,259
10%+ Owner 6,826,448
Director 2,781,888
Director 297,640
Fmr. SVP & Chief Science Off. 181,306
SVP & CFO 177,333
Interim CEO 164,885
SVP & General Counsel 157,967
President and CEO 150,497
Director 148,892
Director 138,239
Director 117,523
Director 111,263
Director 108,718
Fmr. Chief Commercial Officer 87,148
Director 77,279
SVP & Chief Compliance Officer 64,164
SVP & CFO 55,013
Director 43,982
Fmr. CEO and Director 30,085
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the BVS quote page; the site-wide leaderboard is on the insider transactions hub.